Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure,JACC: Heart Failure

当前位置： X-MOL 学术 › JACC Heart Fail. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure
JACC: Heart Failure ( IF 10.3 ) Pub Date : 2024-03-25 , DOI: 10.1016/j.jchf.2024.03.001
Stephen J Greene ₁ , Iyanuoluwa Ayodele ₂ , Jacob B Pierce ₃ , Muhammad Shahzeb Khan ₄ , Sabra C Lewsey ₅ , Clyde W Yancy ₆ , Brooke Alhanti ₂ , Harriette G C Van Spall ₇ , Larry A Allen ₈ , Gregg C Fonarow ₉

Affiliation

U.S. nationwide estimates of the proportion of patients newly diagnosed with heart failure with reduced ejection fraction (HFrEF) eligible for quadruple medical therapy, and the associated benefits of rapid implementation, are not well characterized.

中文翻译：